Therefore, these researches demonstrate that CAAs promote tumor progression by releasing FAs (via CD36/FABPs) to fuel ovarian cancer cell growth, metastasis, and chemoresistance through enhanced FAO. This evidence concerns the gene CD36 and neoplasm.